April 15th - 16th 2014, Campinas/SP - Brazil
The Ceva Poultry Vaccinology Summit 2014 took place in Campinas/SP, Brazil, from April 15th - 16th 2014 and was focused on present and future solutions for poultry disease control.
The two-day summit was a unique opportunity to bring together some of the most renowned poultry scientists in immunology, poultry pathology, incubation and vaccinology along with our customers and colleagues from across Latin America.
As part of Ceva's commitment to the poultry industry, this event was aimed at helping producers to master the control of Gumboro disease, Infectious bronchitis and Newcastle disease which are some of the most challenging avian diseases with major negative impacts on chicken production.
Our ultimate goal is to help you improve your disease control measures and performance in your day-to-day activity.
Tuesday, April 15th 2014
- Evolution of vaccination practice around the world since 2008, Sylvain Comte, Ceva Corporate, France.
- New technology vaccine development: A Look to the Future, Kristi Moore Dorsey, Ceva Biomune Campus, USA .
- Immunological specificity of new technology vaccines, Bénédicte Lambrecht, Coda Cerva, Belgium.
- Importance of the evolution and control of infectious diseases, L Felipe Caron, UFPR, Curitiba, Brazil.
- Overview of IBD epidemiology in LATAM and Global, Vilmos Palya, Ceva Phylaxia, Hungary.
- New approach to Gumboro disease control. Recent findings and application to the field, Yannick Gardin, Ceva Corporate, France.
- Recent field data on IBD control, Luiz Sesti, CEVA Latin America.
Wednesday, April 16th 2014
- Newcastle disease control in Europe and Asia, Marcelo Paniago, Ceva Corporate, France.
- New opportunity for Newcastle disease control in Latin America, Luiz Sesti, CEVA Latin America.
- Recent status of IBD epidemiology worldwide, Kannan Ganapathy, University of Liverpool, UK.
- New challenges on Infections Bronchitis Protection in Brazil and Latin America, Antonio Piantino, USP, Sao Paulo, Brazil.
- Inside the development of a IB vaccine, Jorge Chacon, Ceva Brazil.
- Today’s perspective for IB control: recent findings, Yannick Gardin, Ceva Corporate, France.